Imprivata Inc (IMPR) : Tamarack Advisers Lp reduced its stake in Imprivata Inc by 23.4% during the most recent quarter end. The investment management company now holds a total of 1,309,800 shares of Imprivata Inc which is valued at $25,069,572 after selling 400,200 shares in Imprivata Inc , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.Imprivata Inc makes up approximately 8.55% of Tamarack Advisers Lp’s portfolio.
Other Hedge Funds, Including , Jacobs Levy Equity Management Inc reduced its stake in IMPR by selling 3,800 shares or 8.09% in the most recent quarter. The Hedge Fund company now holds 43,198 shares of IMPR which is valued at $826,810. Imprivata Inc makes up approx 0.02% of Jacobs Levy Equity Management Inc’s portfolio. Laurion Capital Management Lp added IMPR to its portfolio by purchasing 429,600 company shares during the most recent quarter which is valued at $8,222,544. Imprivata Inc makes up approx 0.49% of Laurion Capital Management Lp’s portfolio. Rhumbline Advisers added IMPR to its portfolio by purchasing 13,206 company shares during the most recent quarter which is valued at $252,763.Paradigm Capital Management Incny boosted its stake in IMPR in the latest quarter, The investment management firm added 36,600 additional shares and now holds a total of 839,900 shares of Imprivata Inc which is valued at $16,033,691. Imprivata Inc makes up approx 1.81% of Paradigm Capital Management Incny’s portfolio.California State Teachers Retirement System boosted its stake in IMPR in the latest quarter, The investment management firm added 14,102 additional shares and now holds a total of 33,567 shares of Imprivata Inc which is valued at $641,465.
Imprivata Inc (IMPR) witnessed a volatile trading activity on Thursday , and eventually ended flat at 0.00% or 0 points without letting the bulls or bears take much advantage. The trading began at $19.2 and reached the intraday high at $19.225. The bulls started the profit booking and pushed the shares to intraday low of $19.18. The trading session was marked by a volume range of 1,82,363 shares exchanging hands. The 52-week high of the shares is $20.58 and the 52-week low is $9. The market cap of the company stands at $491 M and there are 2,55,73,159 shares in public circulation.
On the company’s financial health, Imprivata Inc reported $-0.21 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on May 3, 2016. Analyst had a consensus of $-0.31. The company had revenue of $31.52 million for the quarter, compared to analysts expectations of $29.28 million. The company’s revenue was up 22.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.24 EPS.
Many Wall Street Analysts have commented on Imprivata Inc. Imprivata Inc was Downgraded by Wells Fargo to ” Market Perform” on Aug 2, 2016. Imprivata Inc was Downgraded by Leerink Partners to ” Mkt Perform” on Jul 14, 2016. Imprivata Inc was Downgraded by Piper Jaffray to ” Neutral” on Jul 13, 2016.
Imprivata Inc. is a provider of healthcare information technology) IT security solutions. The Company’s solutions provide authentication management access to patient information and communications technologies to the healthcare industry. Its solutions include Imprivata OneSign Imprivata Cortext and Imprivata Confirm ID. Imprivata OneSign is a suite of authentication and access management products which consists of three offerings: authentication management enterprise single sign-on and workflow automation. Imprivata Cortext is a cloud-supported communications platform that provides healthcare organizations with texting and messaging services. Imprivata Confirm ID is a software product for electronic prescribing of controlled substances (EPCS).